1spatial Holdings Share News (SPA)

SR Pharma plans more pre-clinical Atu027 tests, gets AtuRNAi milestone payment

LONDON (Thomson Financial) - SR Pharma PLC said it intends to carry out more pre-clinical testing on its lead molecule Atu027, its first RNAi ca
[26 Apr '07]

SR Pharma chairman Iain Ross buys 100,000 shares in co at 75.75p each

LONDON (AFX) - SR Pharma PLC said chairman Iain Ross yesterday bought 100,000 shares at 75.75 pence each, giving him a 0.09 pct stake in the com
[3 Apr '07]

SR Pharma annual losses widen

LONDON (AFX) - SR Pharma PLC, which specialises in RNAi-based therapeutics, reported widening annual losses on higher research and development c
[30 Mar '07]

UK smallcap opening - Advent Air ticks up on interim profits surge

LONDON (AFX) - Advent Air ticked up 1/2 to 13-1/4 pence after the company revealed a 245 pct leap in first-half pretax profits on the back of gr
[16 Mar '07]

SR Pharma says FDA approves investigational application for second siRNA product

LONDON (AFX) - SR Pharma PLC said the US Food and Drug Administration has approved an Investigational New Drug application for a second small in
[16 Mar '07]

SR Pharma to get 1.5 mln usd milestone payment as blindness drug trial starts

LONDON (AFX) - Biopharmaceutical company SR Pharma PLC said it will get a 1.5 mln usd milestone payment to mark the start of a clinical trial on
[5 Feb '07]

SR Pharma to conduct full toxicological evaluation of RNAi candidate Atu027

LONDON (AFX) - Biopharmaceutical company SR Pharma PLC said it will proceed with a full, 28-day toxicological evaluation of its RNAi product can
[30 Jan '07]

RPT SR Pharma granted core RNAi patent by European Patent Office

(repeating to remove text from bottom of story) LONDON (AFX) - SR Pharma plc said the European Patent Office has granted the company its cor
[3 Jan '07]